Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
1
20%
Ph not_applicable
3
60%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution4 total trials
Phase 2Efficacy & side effects
1(25.0%)
N/ANon-phased studies
3(75.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(2)
Completed(3)

Detailed Status

Completed3
Not yet recruiting1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (25.0%)
N/A3 (75.0%)

Trials by Status

completed360%
not_yet_recruiting120%
recruiting120%

Recent Activity

1 active trials
Showing 5 of 5
recruiting

Diaphragm Structure and Pathobiology in Patients Being Bridged to Lung Transplant

NCT03667027
completednot_applicable

NIV Versus HFO Versus Standard Therapy Immediately After Weaning From Mechanical Ventilation in ARDS Patients

NCT06332768
not_yet_recruitingnot_applicable

Treatment of Acute Hypercapnic Respiratory Failure With OptiflowTM or Optiflow+DuetTM Nasal Cannula in COPD-patients

NCT06257667
completednot_applicable

A Comparison of Intellivent-ASV Mode With Conventional Modes in Patients With BMI >35

NCT04973917
completedphase_2

Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia

NCT01503801

Clinical Trials (5)

Showing 5 of 5 trials
NCT03667027

Diaphragm Structure and Pathobiology in Patients Being Bridged to Lung Transplant

Recruiting
NCT06332768Not Applicable

NIV Versus HFO Versus Standard Therapy Immediately After Weaning From Mechanical Ventilation in ARDS Patients

Completed
NCT06257667Not Applicable

Treatment of Acute Hypercapnic Respiratory Failure With OptiflowTM or Optiflow+DuetTM Nasal Cannula in COPD-patients

Not Yet Recruiting
NCT04973917Not Applicable

A Comparison of Intellivent-ASV Mode With Conventional Modes in Patients With BMI >35

Completed
NCT01503801Phase 2

Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5